AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...

AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...

Clinical benefits of the interleukin-33 inhibitor were observed in a broad population, including both former and current smokers, regardless of eosinophil levels. Topline results were announced from ...

Hydrogen peroxide is a common ingredient in over-the-counter teeth whitening products and in-office dental teeth whitening treatments. You can make a teeth whitening rinse or paste at home using a 3% ...

Rival treatments had mixed results in the past AstraZeneca sees $3-5 billion peak annual sales for its drug Detailed results to be presented at upcoming medical conference Shares among biggest gainers ...

China aims to lower the price of green hydrogen and expand its use to more sectors, doubling down on the costly clean fuel as uncertainty rocks global energy markets. The nation will soon launch a ...

While many people have already heard about gas and electric vehicle options, there's a specific EV option called hydrogen-powered cars. These vehicles use electricity to power the motor, but they use ...